Details for Patent: 11,752,198
✉ Email this page to a colleague
Which drugs does patent 11,752,198 protect, and when does it expire?
Patent 11,752,198 protects WEGOVY and is included in one NDA.
This patent has twenty-five patent family members in nineteen countries.
Drugs Protected by US Patent 11,752,198
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-001 | Jun 4, 2021 | RX | Yes | Yes | 11,752,198 | ⤷ Subscribe | Y | METHOD FOR WEIGHT MANAGEMENT | ⤷ Subscribe | |||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-002 | Jun 4, 2021 | RX | Yes | Yes | 11,752,198 | ⤷ Subscribe | Y | METHOD FOR WEIGHT MANAGEMENT | ⤷ Subscribe | |||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-003 | Jun 4, 2021 | RX | Yes | Yes | 11,752,198 | ⤷ Subscribe | Y | METHOD FOR WEIGHT MANAGEMENT | ⤷ Subscribe | |||
| Novo | WEGOVY | semaglutide | SOLUTION;SUBCUTANEOUS | 215256-004 | Jun 4, 2021 | RX | Yes | Yes | 11,752,198 | ⤷ Subscribe | Y | METHOD FOR WEIGHT MANAGEMENT | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,752,198
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 112480 | ⤷ Subscribe | |||
| Australia | 2018321157 | ⤷ Subscribe | |||
| Brazil | 112020002804 | ⤷ Subscribe | |||
| Canada | 3082033 | ⤷ Subscribe | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
